Aizza Hassan

Aizza Hassan has extensive work experience in the pharmaceutical and medical research industry. Aizza is currently the Head of US Clinical Program Operations at MorphoSys, a role they have held since January 2021. Prior to this, they worked as the Director of Medical Research at Alnylam Pharmaceuticals from January 2019 to January 2021. Aizza also served as the Clinical Projects Lead at Alexion Pharmaceuticals, Inc. from June 2017 to January 2019. Before joining Alexion Pharmaceuticals, they worked at Shire as the Clinical Programs Lead from June 2013 to June 2017 and as a Project Manager from November 2012 to June 2013. Aizza's earlier experience includes working as a Clinical Scientist at Merck from 2006 to 2012, a Research Assistant at Yale University School of Medicine from 2005 to 2006, and a Clinical Research Assistant at Joslin Diabetes Center from 2003 to 2004.

Aizza Hassan holds a Bachelor's Degree in Neuroscience from Wellesley College. Aizza also has a Master's Degree in Epidemiology from Yale School of Public Health. Additionally, they have attended Yale University, although no specific degree or field of study is provided.